Synfacts, Inhaltsverzeichnis

Synfacts 2022; 18(09): 1025
DOI: 10.1055/s-0041-1738304

Innovative Drug Discovery and Development

Synthesis of Danuglipron: An Orally Available GLP-1R Agonist

Rezensent(en):

Antonia F. Stepan (Roche)

,

Ferdinand H. Lutter (Janssen Pharmaceutica)